Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 September;57(3) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 September;57(3):283-95

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Rivista di Medicina Nucleare e Imaging Molecolare


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,481


eTOC

 

REVIEWS  CHARACTERIZATION OF TUMOR HYPOXIA: ADVANCED IMAGING AND IMPLICATIONS FOR THERAPY


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 September;57(3):283-95

Copyright © 2013 EDIZIONI MINERVA MEDICA

lingua: Inglese

Targeted therapies and hypoxia imaging

Ali R., Graves E. E.

Department of Radiation Oncology, Stanford University, Stanford, CA, USA


PDF  


Hypoxia-specific cytotoxins have long exhibited considerable promise for treating hypoxic tumors, however recent negative results in large scale clinical trials have highlighted the importance of selecting patients who are most likely to respond using hypoxia imaging methods. This review looks at the available hypoxia-specific cytotoxins and describes how existing hypoxia imaging methods can be best used to predict which tumors will respond. It then surveys prior studies which combine hypoxia-selective cytotoxin treatment with hypoxia imaging, and finally concludes with a discussion of what lessons can be learnt from previous experiences in order to improve the use of these cytotoxic agents in future clinical evaluations.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail

egraves@stanford.edu